Expression levels of interferon- ɣ and type 2 deiodinase in patients diagnosed with recurrent depressive disorders.

CONCLUSION: This is the first study to reveal that one may cautiously suggest that DIO2 may be involved in the development and/or progression of rDD. The mechanisms of TH regulation on depression, however, need further investigation.
PMID: 29367100 [PubMed - as supplied by publisher]

Source: Pharmacological Reports - January 20, 2018 Category: Drugs & Pharmacology Authors: Gałecka E, Talarowska M, Maes M, Su KP, Górski P, Kumor-Kisielewska A, Szemraj J Tags: Pharmacol Rep Source Type: research